[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BioMedWire Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1275894206469267456.png) BioMedWire [@BioMedWire](/creator/twitter/BioMedWire) on x 1295 followers
Created: 2025-07-16 18:00:21 UTC

$AZN experimental drug for transthyretin amyloidosis did not meet its main goal in a late-stage trial, dealing a setback in the race for rare disease treatments:

#AstraZeneca #ClinicalTrials #PharmaNews #Biotech #HealthUpdate

![](https://pbs.twimg.com/card_img/1943173367026077697/n33_v2Ug?format=jpg&name=800x419)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945544045796762094/c:line.svg)

**Related Topics**
[azn astrazeneca](/topic/azn-astrazeneca)
[manat](/topic/manat)
[$azn](/topic/$azn)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/BioMedWire/status/1945544045796762094)